tiprankstipranks
Advertisement
Advertisement
HeartBeam completes patient enrollment in ALIGN-ACS pilot study
PremiumThe FlyHeartBeam completes patient enrollment in ALIGN-ACS pilot study
19d ago
HeartBeam (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy 
Premium
TipRanks Newswire
HeartBeam (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy 
24d ago
HeartBeam restructures to license 3D ECG technology
Premium
Company Announcements
HeartBeam restructures to license 3D ECG technology
25d ago
HeartBeam announces peer-reviewed article in JACC on HeartBeam ECG
PremiumThe FlyHeartBeam announces peer-reviewed article in JACC on HeartBeam ECG
2M ago
HeartBeam (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
Premium
TipRanks Newswire
HeartBeam (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
2M ago
HeartBeam price target lowered to $2.50 from $5.50 at H.C. Wainwright
Premium
The Fly
HeartBeam price target lowered to $2.50 from $5.50 at H.C. Wainwright
2M ago
HeartBeam (NASDAQ: BEAT) Launches Pilot Study for On-Demand 12-Lead ECG Patch in Coronary Artery Disease Patients
PremiumTipRanks NewswireHeartBeam (NASDAQ: BEAT) Launches Pilot Study for On-Demand 12-Lead ECG Patch in Coronary Artery Disease Patients
2M ago
HeartBeam initiates pilot study of first on-demand 12-lead ECG patch
Premium
The Fly
HeartBeam initiates pilot study of first on-demand 12-lead ECG patch
2M ago
Is BEAT a Buy, Before Earnings?
Premium
Pre-Earnings
Is BEAT a Buy, Before Earnings?
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100